Among the 721 NSCLC patients, the EGFR mutation rate detected in the surgical specimens (42.1%) was not significantly different from that of the small biopsy specimens (42.4%) (P > 0.05) (Table 2). Here, EGFR is linked to non-small cell lung carcinoma.